NSAIDs prevent early sign of Alzheimer disease in mice

November 09, 2009

If taking nonsteroidal antiinflammatory drugs (NSAIDs) such as ibuprofen or naproxen is to protect you from developing Alzheimer disease then you will have to start taking them at a very early age according to research in a mouse model of the disease.

Emerging data indicate that an early molecular event in the development of Alzheimer disease is the induction of neuronal cell cycle events (CCEs). While searching for triggers of neuronal CCEs, a team of researchers led by Karl Herrup, at The State University of New Jersey, Piscataway, and Bruce Lamb, at the Cleveland Clinic, Cleveland, developed two lines of experimental evidence implicating a role for neuroinflammation in the process in a mouse model of Alzheimer disease. First, administration of the inflammatory molecule LPS induced the early appearance of neuronal CCEs. Second, treatment with either ibuprofen or naproxen blocked the induction of neuronal CCEs. Importantly, although no new neuronal CCEs were induced when older mice were treated with either of these NSAIDs, existing neuronal CCEs persisted. These data provide a potential explanation for observations in humans: retrospective studies indicate long-term NSAID use is protective against AD, whereas prospective NSAID clinical trials have been unsuccessful in patients with mild to moderate AD.
-end-
TITLE: NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease

AUTHOR CONTACT:

Karl Herrup
The State University of New Jersey, Piscataway, New Jersey, USA.
Phone: (732) 445-1794; Fax: (732) 445-3306; E-mail: herrup@biology.rutgers.edu.

Bruce T. Lamb
Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Phone: (216) 444-3592; Fax: (216) 444-7927; E-mail: lambb@ccf.org.

View this article at: http://www.jci.org/articles/view/39716?key=FZ0P005I36nTaBOsg7d1

JCI Journals

Related Alzheimer Disease Articles from Brightsurf:

Potential link for Alzheimer's disease and common brain disease that mimics its symptoms
A new study by investigators from Brigham and Women's Hospital uncovered a group of closely related genes that may capture molecular links between Alzheimer's disease and Limbic-predominant Age-related TDP-43 Encephalopathy, or LATE, a recently recognized common brain disorder that can mimic Alzheimer's symptoms.

Uncovering Alzheimer's disease
Characterized by a buildup of amyloid plaques in the brain, Alzheimer's is an irreversible disease that leads to memory loss and a decrease in cognitive function.

Viewpoint: Could disease pathogens be the dark matter behind Alzheimer's disease?
In a lively discussion appearing in the Viewpoint section of the journal Nature Reviews Neurology, Ben Readhead, a researcher in the ASU-Banner Neurodegenerative Disease Research Center at the Biodesign Institute joins several distinguished colleagues to discuss the idea that bacteria, viruses or other infectious pathogens may play a role in Alzheimer's disease.

Coordination chemistry and Alzheimer's disease
It has become evident recently that the interactions between copper and amyloid-╬▓ neurotoxically impact the brain of patients with Alzheimer's disease.

How Alzheimer's disease spreads through the brain
Tau can quickly spread between neurons but is not immediately harmful, according to research in mouse neurons published in JNeurosci.

A protective factor against Alzheimer's disease?
Researchers at the German Center for Neurodegenerative Diseases (DZNE) and the Institute for Stroke and Dementia Research (ISD) at the University Hospital of the Ludwig-Maximilians-Universit├Ąt (LMU) in Munich have found that a protein called TREM2 could positively influence the course of Alzheimer's disease.

An alternate theory for what causes Alzheimer's disease
Alzheimer's disease, the most common cause of dementia among the elderly, is characterized by plaques and tangles in the brain, with most efforts at finding a cure focused on these abnormal structures.

Alzheimer's: How does the brain change over the course of the disease?
What changes in the brain are caused by Alzheimer's disease?

Possible pathway to new therapy for Alzheimer's disease
Researchers have uncovered an enzyme and a biochemical pathway they believe may lead to the identification of drugs that could inhibit the production of beta-amyloid protein, the toxic initiator of Alzheimer's disease (AD).

Promising novel treatment against Alzheimer disease
New research conducted at the Lady Davis Institute (LDI) at the Jewish General Hospital reveals that a novel drug reverses memory deficits and stops Alzheimer disease pathology (AD) in an animal model.

Read More: Alzheimer Disease News and Alzheimer Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.